Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: Fosamax Products
Case Number:
12-2250
Court:
Nature of Suit:
4365 Personal Injury-Product Liability
Companies
Sectors & Industries:
-
April 30, 2014
3rd Circ. Shuts Down Generic Fosamax Appeal
The Third Circuit on Wednesday upheld a lower court ruling that generic manufacturers of equivalents of the bone drug Fosamax could not be held liable for injuries supposedly incurred by drug users, concluding that the state-law claims asserted in the suit were preempted by federal law.
-
December 18, 2013
3rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal
The Third Circuit on Wednesday questioned whether it had jurisdiction to hear an appeal in a case that seeks to hold generic-drug manufacturers responsible for injuries allegedly caused by their versions of the bone drug Fosamax.
-
September 24, 2013
Mensing Doesn't Nix Generic-Fosamax Claims, 3rd Circ. Told
A federal judge wrongfully used the U.S. Supreme Court's Pliva Inc. v. Mensing ruling to preempt design defect claims against generic-drug makers in multidistrict litigation over the safety of Merck & Co.'s bone drug Fosamax, according to a briefing filed Monday with the Third Circuit.